Clinical Trial Update: Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a carbonaceous oral adsorbent for slowing progression of chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Carbonaceous Oral Adsorbent

Snippet

Sponsor: Institute for Health Outcomes and Process Evaluation Reseach | Conditions: Kidney Failure, Chronic | Phase 4 | Status: COMPLETED